نتائج البحث 331-340 من 10402 لعملية البحث عن oral
Patients randomized to GDC-0199+R will be given GDC-0199 daily (oral, target dose 400 mg) and will receive 6 cycles of rituximab infused intravenously (IV) ...
James M. Van Ess, M.D., D.D.S.. Oral and Maxillofacial Surgeon. Rochester, MN ...
Monoclonal antibodies, such as cetuximab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor ...
... Oral biopsy, Cancer, Head and neck cancer, Facial fracture, Osteoradionecrosis, Chondrosarcoma, Nasal and paranasal tumors, Thyroid cancer, Soft tissue ...
... (Oral Anti-Platelet) agents. In addition to exploring ED treatment patterns and success of both ischemic and bleeding risk stratification prior to definition ...
... Oral appliance ther...apy, Head and neck reconstruction, Dental surgery, Cancer, Head and neck cancer, Facial fracture, Mouth cancer, Jaw tumors and cysts ...
... Oral and throat cancer, Laryngeal cancer, Salivary gland cancer, Skin lesion. إظهار المزيد من مجالات التخصص من أجل Kendall K. Tasche, M.D.. طلب تحديد موعد.
D.M.D.. Oral and Maxillofacial Surgeon. Rochester, MN. مناطق التركيز: Joint replacement surgery, Scar revision, Trauma care, Total TMJ replacement, Minimally ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.